Hybrid Nanoreactors: Enabling an Off-the-Shelf Strategy for Concurrently Enhanced Chemo-immunotherapy
Date
2018
Authors
Yang, Y.
Tang, J.
Abbaraju, P.L.
Jambhrunkar, M.
Song, H.
Zhang, M.
Lei, C.
Fu, J.
Gu, Z.
Liu, Y.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
Angewandte Chemie International Edition, 2018; 57(36):11764-11769
Statement of Responsibility
Conference Name
Abstract
Immunosuppressive tumors generally exhibit poor response to immune checkpoint blockade based cancer immunotherapy. Rationally designed hybrid nanoreactors are now presented that have integrated functions as Fenton catalysts and glutathione depletion agents for amplifying the immunogenic cell death and activating immune cells. A simple physical mixture of nanoreactors and chemodrugs in combination with immune checkpoint blockades show synergistically and concurrently enhanced chemo-immunotherapy efficacy, inhibiting the growth of both treated primary immunosuppressive tumors and untreated distant tumors. The off-the-shelf strategy uses tumor antigens generated in situ and avoids cargo loading, and is thus a substantial advance in personalized nanomedicine for clinical translation.
School/Discipline
Dissertation Note
Provenance
Description
Access Status
Rights
Copyright 2018 Wiley